arrow
F

Fabio Nicolini

irccs istituto romagnolo per lo studio dei tumori (irst) 'dino amadori'
H指数:20
被引数:1,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CORSA study finds spike-specific blunted immune responses in lymphoma patients after SARS-CoV-2 vaccine

CORSA研究发现在淋巴瘤患者接种SARS-CoV-2疫苗后出现针对刺突蛋白的免疫应答减弱现象

2026-05-200
OAAI
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability

优化非病毒 Sleeping Beauty 介导的 CARCIK 细胞的 GMP 级生产,以增强其适应性和临床可扩展性

2025-05-190
OA
A large-scale database of T-cell receptor beta sequences and binding associations from natural and synthetic exposure to SARS-CoV-2
2025-02-171
OAAI
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
2025-02-100
OAAI
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels

在个人和人群水平上对SARS-CoV-2感染的T细胞反应的大小和动态

2025-01-070
OAAI
An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy

一项意大利现实世界研究强调了一些临床病理特征的重要性,这些特征可用于识别对CDK4/6抑制剂和激素治疗耐药的转移性乳腺癌患者

2024-02-224
OAAI
ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

ACE2和TMPRSS2可能参与癌症患者对SARS-COV-2的遗传易感性

2020-10-2725
OAAI